Total Payments
$1,219
2023 Payments
$46.48
Companies
18
Transactions
66
Medicare Patients
1,642
Medicare Billing
$271,183
Payment Breakdown by Category
Food & Beverage$1,219 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,219 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $316.71 | 16 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $193.85 | 6 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $144.24 | 11 | $0 (2022) |
| GlaxoSmithKline, LLC. | $82.95 | 4 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $81.47 | 5 | $0 (2021) |
| ABBVIE INC. | $76.41 | 4 | $0 (2023) |
| Amgen Inc. | $52.70 | 3 | $0 (2021) |
| Lilly USA, LLC | $51.24 | 3 | $0 (2021) |
| Esperion Therapeutics, Inc. | $48.85 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $31.14 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $46.48 | 2 | ABBVIE INC. ($46.48) |
| 2022 | $96.09 | 6 | Novo Nordisk Inc ($45.63) |
| 2021 | $1,077 | 58 | Novo Nordisk Inc ($271.08) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Obesity | ||||||
| 02/08/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Obesity | ||||||
| 02/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: DIABETES | ||||||
| 01/11/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: RESPIRATORY | ||||||
| 01/04/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Obesity | ||||||
| 12/14/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardio-renal | ||||||
| 12/10/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: Obesity | ||||||
| 12/07/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: PRIMARY CARE | ||||||
| 11/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: DIABETES | ||||||
| 11/02/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: DIABETES | ||||||
| 10/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/02/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: Cardiovascular | ||||||
| 08/24/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes | ||||||
| 08/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 638 | 2,114 | $284,866 | $142,051 |
| 2022 | 7 | 513 | 1,778 | $231,418 | $100,722 |
| 2021 | 5 | 194 | 279 | $53,276 | $13,756 |
| 2020 | 7 | 297 | 414 | $74,615 | $14,654 |
Total Patients
1,642
Total Services
4,585
Medicare Billing
$271,183
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 179 | 1,014 | $139,437 | $72,521 | 52.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 163 | 714 | $74,211 | $35,579 | 47.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 151 | 166 | $41,608 | $20,215 | 48.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 55 | 91 | $18,536 | $9,348 | 50.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 54 | 89 | $5,900 | $2,367 | 40.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 36 | 40 | $5,174 | $2,021 | 39.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 145 | 752 | $102,511 | $45,888 | 44.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 134 | 735 | $76,368 | $33,931 | 44.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 93 | 101 | $25,199 | $11,141 | 44.2% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 43 | 59 | $12,084 | $5,310 | 43.9% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 47 | 76 | $5,038 | $2,233 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 35 | $7,630 | $1,178 | 15.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 20 | 20 | $2,587 | $1,041 | 40.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 183 | $39,894 | $9,810 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 32 | $10,336 | $2,404 | 23.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $1,620 | $1,170 | 72.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $1,020 | $279.74 | 27.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 20 | 29 | $406.00 | $91.93 | 22.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 165 | 269 | $58,642 | $10,211 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 35 | $11,305 | $2,300 | 20.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 25 | 25 | $2,250 | $1,525 | 67.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 28 | 28 | $1,680 | $437.94 | 26.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 26 | 33 | $330.00 | $73.75 | 22.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 12 | 12 | $240.00 | $68.41 | 28.5% |
| 81001 | Manual urinalysis test with examination using microscope | Office | 2020 | 12 | 12 | $168.00 | $38.04 | 22.6% |
About Dorian Cerrato, NP
Dorian Cerrato, NP is a Family healthcare provider based in Denton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1114588753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dorian Cerrato, NP has received a total of $1,219 in payments from pharmaceutical and medical device companies, with $46.48 received in 2023. These payments were reported across 66 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,219).
As a Medicare-enrolled provider, Cerrato has provided services to 1,642 Medicare beneficiaries, totaling 4,585 services with total Medicare billing of $271,183. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Denton, TX
- Active Since 06/25/2019
- Last Updated 11/17/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1114588753
Products in Payments
- FARXIGA (Drug) $179.28
- Wegovy (Drug) $128.79
- Ozempic (Drug) $98.33
- JARDIANCE (Drug) $89.86
- Saxenda (Drug) $89.59
- TRELEGY ELLIPTA (Drug) $82.95
- BELSOMRA (Drug) $81.47
- STIOLTO RESPIMAT (Drug) $54.38
- NEXLETOL (Drug) $48.85
- Aimovig (Biological) $37.19
- TRULICITY (Drug) $33.72
- UBRELVY (Drug) $33.09
- XARELTO (Drug) $31.14
- VRAYLAR (Drug) $28.87
- ELIQUIS (Drug) $28.19
- MYRBETRIQ (Drug) $19.31
- NURTEC ODT (Drug) $18.90
- EMGALITY (Drug) $17.52
- Kerendia (Drug) $16.76
- ADUHELM (Biological) $15.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Denton
Ms. Christina Keil, Np, NP
Family — Payments: $4,642
Family $4,642
Karen Dodge, Np, NP
Family — Payments: $4,407
Family $4,407
Mrs. Jennifer Kamp, Fnp-C, FNP-C
Family — Payments: $4,326
Family $4,326
Melissa Rodriguez
Family — Payments: $4,230
Family $4,230
Jennifer Nuspel, F.n.p, F.N.P
Family — Payments: $3,088
Family $3,088
Brandi Clokey, Fnp-C, FNP-C
Family — Payments: $2,843
Family $2,843